Skip to content
UniqueBaseEN
For AI ↗
Companies

Keyin Biotechnology

Transliterated name · original name retained below

Developer of innovative drugs using AI.

Snapshot

As of Oct 15, 2026, UniqueBase lists 1 funding record for Keyin Biotechnology.

Funding records
1
Latest round
—
Total raised (reported)
—
Rows with a source link
0 of 1

Overview

Keyin Biotech is an AI innovative drug developer.

Funding · 1

Funding

Amounts as reported; USD estimates shown only when they match

Listed 1 funding record.

Annual trendUnit: USD

No chartable funding estimates yet.

1 listed record lack a clear date or positive USD estimate for the chart.

DateAmountInvestorsSources
Dec 20, 2022Undisclosed · Strategic乾广旺利, 函数资本, 宜信, 峰瑞资本 No source link

Select ▸ on a row to see its source brief and links.

Valuation · 1

Valuation

Amounts as reported; USD estimates shown only when they match

Listed 1 valuation record.

Annual trendUnit: USD

No chartable valuation estimates yet.

1 listed record lack a clear date or positive USD estimate for the chart.

DateAmountInvestorsSources
Dec 20, 2022— · Strategic乾广旺利, 函数资本, 宜信, 峰瑞资本 No source link

Select ▸ on a row to see its source brief and links.

Revenue

Revenue

Amounts as reported; USD estimates shown only when they match

No revenue records are listed yet.

Team, products & investors

Explore

More Industry apps companies

Sources · 0

Sources & provenance

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

AI创新药物研发商 科因生物是一家AI创新药物研发商